Barrett Asset Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $51.4M | Sell |
316,793
-3,728
| -1% | -$542K | 2.15% | 15 |
|
|
2021
Q4 | $43.4M | Buy |
320,521
+43,829
| +16% | +$5.18M | 1.64% | 22 |
|
|
2021
Q3 | $29.8M | Buy |
276,692
+1,752
| +0.6% | +$200K | 1.37% | 28 |
|
|
2021
Q2 | $31M | Buy |
274,940
+1,900
| +0.7% | +$214K | 1.43% | 24 |
|
|
2021
Q1 | $29.5M | Buy |
273,040
+4,256
| +2% | +$455K | 1.47% | 24 |
|
|
2020
Q4 | $28.8M | Buy |
268,784
+949
| +0.4% | +$91.2K | 1.51% | 25 |
|
|
2020
Q3 | $23.5M | Buy |
267,835
+7,850
| +3% | +$739K | 1.38% | 28 |
|
|
2020
Q2 | $25.5M | Buy |
259,985
+910
| +0.4% | +$80.1K | 1.63% | 24 |
|
|
2020
Q1 | $19.7M | Buy |
259,075
+960
| +0.4% | +$81.8K | 1.54% | 26 |
|
|
2019
Q4 | $22.9M | Buy |
258,115
+2,495
| +1% | +$207K | 1.4% | 27 |
|
|
2019
Q3 | $19.4M | Sell |
255,620
-14,725
| -5% | -$1.01M | 1.28% | 30 |
|
|
2019
Q2 | $19.7M | Sell |
270,345
-65,624
| -20% | -$5.16M | 1.3% | 28 |
|
|
2019
Q1 | $27.1M | Sell |
335,969
-29,214
| -8% | -$2.39M | 1.82% | 24 |
|
|
2018
Q4 | $33.7M | Sell |
365,183
-4,025
| -1% | -$354K | 2.59% | 13 |
|
|
2018
Q3 | $34.9M | Sell |
369,208
-3,430
| -0.9% | -$325K | 2.27% | 14 |
|
|
2018
Q2 | $34.5M | Buy |
372,638
+2,277
| +0.6% | +$222K | 2.34% | 14 |
|
|
2018
Q1 | $35.1M | Buy |
370,361
+2,649
| +0.7% | +$291K | 2.49% | 14 |
|
|
2017
Q4 | $35.6M | Sell |
367,712
-5,310
| -1% | -$500K | 2.5% | 13 |
|
|
2017
Q3 | $33.1M | Sell |
373,022
-4,075
| -1% | -$310K | 2.41% | 13 |
|
|
2017
Q2 | $27.3M | Buy |
377,097
+15,705
| +4% | +$1.06M | 2.07% | 19 |
|
|
2017
Q1 | $23.5M | Sell |
361,392
-6,570
| -2% | -$413K | 1.86% | 21 |
|
|
2016
Q4 | $23M | Buy |
367,962
+6,225
| +2% | +$380K | 1.91% | 21 |
|
|
2016
Q3 | $22.8M | Buy |
361,737
+4,916
| +1% | +$318K | 1.92% | 20 |
|
|
2016
Q2 | $22.1M | Buy |
356,821
+850
| +0.2% | +$51.8K | 1.91% | 20 |
|
|
2016
Q1 | $20.3M | Buy |
355,971
+6,875
| +2% | +$383K | 1.75% | 22 |
|
|
2015
Q4 | $20.7M | Buy |
349,096
+10,444
| +3% | +$602K | 1.8% | 23 |
|
|
2015
Q3 | $18.4M | Buy |
338,652
+21,440
| +7% | +$1.4M | 1.68% | 26 |
|
|
2015
Q2 | $21.3M | Buy |
317,212
+35,057
| +12% | +$2.29M | 1.75% | 22 |
|
|
2015
Q1 | $16.5M | Buy |
282,155
+166,067
| +143% | +$10M | 1.37% | 31 |
|
|
2014
Q4 | $7.6M | Buy |
116,088
+950
| +0.8% | +$59.9K | 0.6% | 53 |
|
|
2014
Q3 | $6.65M | Buy |
115,138
+803
| +0.7% | +$44.6K | 0.54% | 55 |
|
|
2014
Q2 | $6.45M | Buy |
114,335
+10,580
| +10% | +$555K | 0.53% | 57 |
|
|
2014
Q1 | $5.33M | Buy |
103,755
+2,535
| +3% | +$128K | 0.46% | 60 |
|
|
2013
Q4 | $5.34M | Sell |
101,220
-1,825
| -2% | -$89.7K | 0.47% | 57 |
|
|
2013
Q3 | $4.61M | Buy |
103,045
+5,000
| +5% | +$222K | 0.45% | 59 |
|
|
2013
Q2 | $4.05M | Buy |
+98,045
| New | +$4.29M | 0.41% | 60 |
|
Other funds holding ABBV
Barrett Asset Management's ABBV Position: Q1 2022 in Review
Barrett Asset Management reduced its AbbVie (ABBV) stake by 1.2% in Q1 2022, selling an estimated $542K and leaving 316,793 shares worth $51.4M. The position accounts for 2.15% of the portfolio, ranked #15.
Barrett Asset Management first reported a position in ABBV in Q2 2013 and has held it in 36 quarters since. 3,052 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.
- Barrett Asset Management held 316,793 shares of AbbVie worth $51.4M as of Q1 2022.
- Barrett Asset Management sold 3,728 AbbVie shares in Q1 2022, an estimated $542K.
- AbbVie made up 2.15% of Barrett Asset Management's portfolio in Q1 2022, its #15 holding.
- Barrett Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 36 quarters since.
- 3,052 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.
Based on Barrett Asset Management's 13F filing for Q1 2022, filed 16 May 2022.